Third Dose May Lose Its Effect Against Omicron

Questions about the Omicron variant of the coronavirus, which emerged in the past weeks and caused some restrictions to be re-initiated all over the world, still continue. At the very beginning of these questions is the issue of how the two and three doses of vaccines provide effectiveness against the variant. Making frequent statements about the vaccine and Omicron Uğur Şahin, founder of BioNTechmade another statement today.

prof. Dr. Uğur Şahin, in his statements to the Le Monde newspaper, stated that the first findings from research conducted in Britain, after the third dose The vaccine is around 70% protective. he stated. of this rate after the second dose, it is between 20% and 40%. expressed. Stating that these observations are similar in South Africa, Şahin said that these data against serious illness by 70% provides a protection He added that it showed

“There will be a loss of effect over time”

Answering the question of how long the protection offered by the third dose will last, Şahin said, “There will be a loss of potency over time against Omicron, it’s possible. Real-time data would be more appropriate for me to make an estimation based on the preliminary findings of the studies done in the laboratory.” used the phrases. Şahin explained that there is a risk of contracting the virus in all three doses, with the following words:

“It is clear that we are far from the first 95 percent protection against the virus. In any case, our vaccine is in the third dose, against all kinds of diseases. 70-75 percent protecting. That’s a good ratio for a vaccine overall.”

Uğur Şahin, finally, was asked whether a new vaccine will be developed against the coronavirus. “Our 100-day goal continues. This means a COVID vaccine suitable for Omicron in May, with regulatory approval. means we can improve” gave the answer.